These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6380077)

  • 1. Pathophysiology of renovascular hypertension.
    Textor SC
    Urol Clin North Am; 1984 Aug; 11(3):373-81. PubMed ID: 6380077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
    Laragh JH; Sealey JE; Bühler FR; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Med; 1975 Jan; 58(1):4-13. PubMed ID: 234677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis.
    Pipinos II; Nypaver TJ; Moshin SK; Careterro OA; Beierwaltes WH
    J Vasc Surg; 1998 Jul; 28(1):167-77. PubMed ID: 9685143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of the stenosed and contralateral kidneys to [Sar1, Thr8] AII in human renovascular hypertension.
    Textor SC; Novick A; Mujais SK; Ross R; Bravo EL; Fouad FM; Tarazi RC
    Hypertension; 1983; 5(5):796-804. PubMed ID: 6618641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchangeable sodium in angiotensinogenic and nonangiotensinogenic renovascular hypertension.
    Albertini R; Binia A; Otsuka Y; Carretero OA
    Hypertension; 1979; 1(6):624-30. PubMed ID: 232088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume and vasoconstriction in experimental renovascular hypertension.
    Freeman RH; Davis JO; Seymour AA
    Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of angiotensin on renal function in renal vascular hypertension.
    Ploth DW
    Kidney Int Suppl; 1990 Nov; 30():S97-101. PubMed ID: 2259086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the pathophysiology of renovascular hypertension.
    Romero JC; Feldstein AE; Rodriguez-Porcel MG; Cases-Amenos A
    Mayo Clin Proc; 1997 Mar; 72(3):251-60. PubMed ID: 9070202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of renin release in renovascular hypertension.
    Welch WJ
    Semin Nephrol; 2000 Sep; 20(5):394-401. PubMed ID: 11022891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renovascular hypertension. Concepts and reality].
    Ménard J; Corvol P; Plouin PF; Lagneau P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():5-8. PubMed ID: 43713
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of experimental renovascular hypertension.
    Edmunds ME; Russell GI; Bing RF
    J Hypertens; 1991 Apr; 9(4):289-301. PubMed ID: 1646257
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal influences on maintenance and reversal of two-kidney one-clip renal hypertension.
    Nyström HC; Jia J; Johansson M; Lambert G; Bergström G
    Acta Physiol Scand; 2002 Jul; 175(3):245-51. PubMed ID: 12100364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 18. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells and chronic renal artery stenosis.
    Oliveira-Sales EB; Boim MA
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F6-9. PubMed ID: 26538439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.